Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/16/2023
Amsterdam, the Netherlands – Royal Philips announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the largest ever randomized controlled multicenter clinical trial to...
Amsterdam, the Netherlands – Royal Philips announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the largest ever randomized controlled multicenter clinical trial to...
Amsterdam, the...
05/16/2023
Cath Lab Digest

Advertisement

News
05/16/2023
The company received the CE marking for R-One, its first robotic solution, in 2019. In a prospective, multicenter, non-randomized, single-arm clinical trial, R-One demonstrated safety and efficacy.
The company received the CE marking for R-One, its first robotic solution, in 2019. In a prospective, multicenter, non-randomized, single-arm clinical trial, R-One demonstrated safety and efficacy.
The company received the CE...
05/16/2023
Cath Lab Digest
News
05/15/2023
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
Shockwave C2+ provides 50...
05/15/2023
Cath Lab Digest
News
05/11/2023
Using the new technology, the team discovered that pressure inside the heart goes up when given adenosine for testing the heart’s blood flow. They also found out why adenosine makes patients breathless during the test.
Using the new technology, the team discovered that pressure inside the heart goes up when given adenosine for testing the heart’s blood flow. They also found out why adenosine makes patients breathless during the test.
Using the new technology, the...
05/11/2023
Cath Lab Digest

Advertisement

News
05/11/2023
The study commenced in 2021 and is a prospective, multi-center study to validate the diagnostic performance of the MyoVista wavECG AI algorithm for the detection of impaired left ventricular relaxation.
The study commenced in 2021 and is a prospective, multi-center study to validate the diagnostic performance of the MyoVista wavECG AI algorithm for the detection of impaired left ventricular relaxation.
The study commenced in 2021 and...
05/11/2023
Cath Lab Digest
News
05/11/2023
A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart’s ability to contract properly.
A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart’s ability to contract properly.
A small randomized trial in...
05/11/2023
Cath Lab Digest
News
05/11/2023
Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of similar age, according to research presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC).
Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of similar age, according to research presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC).
Postmenopausal women with...
05/11/2023
Cath Lab Digest

Advertisement

News
05/10/2023
Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic of Georgia Akura’s platform, which will be featured at PCR Innovator’s Day, uses a...
Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic of Georgia Akura’s platform, which will be featured at PCR Innovator’s Day, uses a...
Initial cases, proctored by 2...
05/10/2023
Vascular Disease Management
News
05/10/2023
Data showed that 37.6% of white participants used statins compared with 23.9% of Hispanic participants and 23.8% of Black participants. The study also showed that having health insurance and regular access to routine health care were...
Data showed that 37.6% of white participants used statins compared with 23.9% of Hispanic participants and 23.8% of Black participants. The study also showed that having health insurance and regular access to routine health care were...
Data showed that 37.6% of white...
05/10/2023
Cath Lab Digest
News
05/03/2023
The Guardian™ System is the first and only FDA-approved Class III implantable device designed to detect heart attacks in real-time, including silent and atypical symptomatic heart attacks, providing life-saving alerts to patients and...
The Guardian™ System is the first and only FDA-approved Class III implantable device designed to detect heart attacks in real-time, including silent and atypical symptomatic heart attacks, providing life-saving alerts to patients and...
The Guardian™ System is the...
05/03/2023
Cath Lab Digest

Advertisement

Advertisement